Dean Celia

Online Exclusive

Can California Manufacture Its Own Insulin and Will Patients Benefit?

01/03/2023

Dean Celia

The price of insulin has risen between 5% and 16% since the turn of the century, prompting states like California to take manufacturing into their own hands.

The price of insulin has risen...

01/03/2023

First Report Managed Care

Cover Story

Analyzing the Inflation Reduction Act’s Drug Provisions

12/22/2022

Dean Celia

Pharmaceutical-related measures of the Inflation Reduction Act will be implemented starting in 2023. Will they deliver as promised by the Biden administration and Congressional Democrats? Or will they serve as an impediment to competition,...

Pharmaceutical-related measures...

12/22/2022

First Report Managed Care

Cover Story

Psychedelics & Cannabis, Gaining Clinical Acceptance

09/23/2022

Dean Celia

Small studies are demonstrating value for individuals with depression, alcohol use disorder, and chronic pain. States and localities are showing a willingness to loosen restrictions. But the path to medical coverage is long, narrow, and...

Small studies are demonstrating...

09/23/2022

First Report Managed Care

Feature Story

Panel Discusses New Firearm Legislation & Mental Health Provisions

08/02/2022

Dean Celia

A panel of experts weigh in on new firearm provisions and how they will impact mental health programs moving forward.

A panel of experts weigh in on...

08/02/2022

First Report Managed Care

Cover Story

ICER's Rare Disease Drug Policy Report Analyzed

05/26/2022

Dean Celia

Experts weigh in on 4 proposed reforms and examine each one's impact on payers, patients, providers, and the pharmaceutical industry.

Experts weigh in on 4 proposed...

05/26/2022

First Report Managed Care

Feature

What’s In Store for Medicaid Enrollees as COVID-19 Subsides?

04/18/2022

Dean Celia

The official end to the public health emergency is a welcome sight for most, but for Medicaid enrollees, it could signal disruption as the coverage redetermination process is restored. How will states react, what measures can help the...

The official end to the public...

04/18/2022

First Report Managed Care

Feature Story

The No Surprises Act Becomes Law

01/31/2022

Dean Celia

Does this bipartisan effort demonstrate that lawmakers in Washington are more willing to work together than previously thought to improve health care? What are the implications for payers, providers, and patients? Our experts weigh in.

Does this bipartisan effort...

01/31/2022

First Report Managed Care

Cover Story

Is Medicare Poised to Negotiate Drug Prices?

12/22/2021

Dean Celia

A provision allowing CMS to negotiate with pharmaceutical companies survived the House version of President Biden’s Build Back Better Act that passed in November. Now the Senate is taking it up. Even if the measure clears the Senate and is...

A provision allowing CMS to...

12/22/2021

First Report Managed Care

Cover Story

Vaccinating Against COVID-19 in an Endemic Setting

11/22/2021

Dean Celia

With the virus expectedly here to stay, how should payers prepare for the likely need to purchase and administer vaccinations regularly? How will pricing evolve post-pandemic? Will public perception of COVID factor in? Our panel looks at the...

With the virus expectedly here...

11/22/2021

First Report Managed Care

Feature Story

Will Biden Build Back Better With or Without Drug Measures?

10/28/2021

Dean Celia

With moderate and progressive Democrats finding it difficult to agree on what gets into the Build Back Better Act, it is anyone’s guess which health measures—if any—will make the cut. Our panelists weigh in with their assessment and suggest...

With moderate and progressive...

10/28/2021

First Report Managed Care